Doré JJ, Edens M, Garamszegi N, Leof EB (1998). "Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells". The Journal of Biological Chemistry273 (48): 31770–7. PMID9822641. doi:10.1074/jbc.273.48.31770.
Yanagita M. (2012). "Inhibitors/antagonists of TGF-β system in kidney fibrosis." 27 (10). PMID23114895. doi:10.1093/ndt/gfs381.|data-acceso= require |url= (Axuda)
nih.gov
ncbi.nlm.nih.gov
Doré JJ, Edens M, Garamszegi N, Leof EB (1998). "Heteromeric and homomeric transforming growth factor-beta receptors show distinct signaling and endocytic responses in epithelial cells". The Journal of Biological Chemistry273 (48): 31770–7. PMID9822641. doi:10.1074/jbc.273.48.31770.
Cheifetz S, Andres JL, Massagué J (November 1988). "The transforming growth factor-beta receptor type III is a membrane proteoglycan. Domain structure of the receptor". The Journal of Biological Chemistry263 (32): 16984–91. PMID2903157.
Hui Yao Lan (septiembre de 2011). "Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation" 7 (7). PMID3174390.|data-acceso= require |url= (Axuda)
Yanagita M. (2012). "Inhibitors/antagonists of TGF-β system in kidney fibrosis." 27 (10). PMID23114895. doi:10.1093/ndt/gfs381.|data-acceso= require |url= (Axuda)
